{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T13:29:09Z","timestamp":1787146149077,"version":"build-2736575974"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Science and Technology Project of Xuzhou Municipal Health Commission","award":["XWKYHT20240123"],"award-info":[{"award-number":["XWKYHT20240123"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82473333"],"award-info":[{"award-number":["82473333"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81972242"],"award-info":[{"award-number":["81972242"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Jiangsu Province Social Development Projects","award":["BE2023689"],"award-info":[{"award-number":["BE2023689"]}]},{"name":"XZHMU-QL Joint Research Fund","award":["QL-YB032"],"award-info":[{"award-number":["QL-YB032"]}]},{"name":"Construction Project of High Level Hospital of Jiangsu Province","award":["LCZX202501"],"award-info":[{"award-number":["LCZX202501"]}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"crossref","award":["BK20150216"],"award-info":[{"award-number":["BK20150216"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Natural Science Key Project of Jiangsu Provincial Education Department","award":["20KJA320006"],"award-info":[{"award-number":["20KJA320006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"DOI":"10.1007\/s00262-026-04401-3","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T11:25:26Z","timestamp":1778239526000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Novel recombinant protein PK5-Gal-3C enhances the anti-tumor activity of T cells via binding with TRPV2"],"prefix":"10.1007","volume":"75","author":[{"given":"Guopeng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohuan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feitong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shishuo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangye","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoge","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"key":"4401_CR1","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/s41423-020-0488-6","volume":"17","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Zhang Z (2020) The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications. Cell Mol Immunol 17:807\u2013821. https:\/\/doi.org\/10.1038\/s41423-020-0488-6","journal-title":"Cell Mol Immunol"},{"key":"4401_CR2","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s13045-021-01164-5","volume":"14","author":"S Zhu","year":"2021","unstructured":"Zhu S, Zhang T, Zheng L, Liu H, Song W, Liu D, Li Z, Pan CX (2021) Combination strategies to maximize the benefits of cancer immunotherapy. J Hematol Oncol 14:156. https:\/\/doi.org\/10.1186\/s13045-021-01164-5","journal-title":"J Hematol Oncol"},{"key":"4401_CR3","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.it.2022.04.010","volume":"43","author":"J Zhang","year":"2022","unstructured":"Zhang J, Huang D, Saw PE, Song E (2022) Turning cold tumors hot: from molecular mechanisms to clinical applications. Trends Immunol 43:523\u2013545. https:\/\/doi.org\/10.1016\/j.it.2022.04.010","journal-title":"Trends Immunol"},{"key":"4401_CR4","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.ccell.2020.07.005","volume":"38","author":"M Hong","year":"2020","unstructured":"Hong M, Clubb JD, Chen YY (2020) Engineering CAR-T cells for next-generation cancer therapy. Cancer Cell 38:473\u2013488. https:\/\/doi.org\/10.1016\/j.ccell.2020.07.005","journal-title":"Cancer Cell"},{"key":"4401_CR5","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nrc3245","volume":"12","author":"WH Fridman","year":"2012","unstructured":"Fridman WH, Pages F, Sautes-Fridman C, Galon J (2012) The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer 12:298\u2013306. https:\/\/doi.org\/10.1038\/nrc3245","journal-title":"Nat Rev Cancer"},{"key":"4401_CR6","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1146\/annurev-immunol-101819-024752","volume":"42","author":"HN Bell","year":"2024","unstructured":"Bell HN, Zou W (2024) Beyond the barrier: unraveling the mechanisms of immunotherapy resistance. Annu Rev Immunol 42:521\u2013550. https:\/\/doi.org\/10.1146\/annurev-immunol-101819-024752","journal-title":"Annu Rev Immunol"},{"key":"4401_CR7","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.ccell.2023.02.014","volume":"41","author":"C Tay","year":"2023","unstructured":"Tay C, Tanaka A, Sakaguchi S (2023) Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy. Cancer Cell 41:450\u2013465. https:\/\/doi.org\/10.1016\/j.ccell.2023.02.014","journal-title":"Cancer Cell"},{"key":"4401_CR8","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/imr.13252","volume":"320","author":"GMP Giordano Attianese","year":"2023","unstructured":"Giordano Attianese GMP, Ash S, Irving M (2023) Coengineering specificity, safety, and function into T cells for cancer immunotherapy. Immunol Rev 320:166\u2013198. https:\/\/doi.org\/10.1111\/imr.13252","journal-title":"Immunol Rev"},{"key":"4401_CR9","doi-asserted-by":"publisher","first-page":"132356","DOI":"10.1016\/j.ijbiomac.2024.132356","volume":"270","author":"X Dai","year":"2024","unstructured":"Dai X, Xue P, Bian L (2024) Molecular recognition and interaction between human plasminogen Kringle 5 and A2M domain in human complement C5 by biospecific methods coupled with molecular dynamics simulation. Int J Biol Macromol 270:132356. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.132356","journal-title":"Int J Biol Macromol"},{"key":"4401_CR10","doi-asserted-by":"publisher","first-page":"e3144","DOI":"10.1038\/cddis.2017.528","volume":"8","author":"S Fang","year":"2017","unstructured":"Fang S, Hong H, Li L et al (2017) Plasminogen kringle 5 suppresses gastric cancer via regulating HIF-1alpha and GRP78. Cell Death Dis 8:e3144. https:\/\/doi.org\/10.1038\/cddis.2017.528","journal-title":"Cell Death Dis"},{"key":"4401_CR11","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s10555-017-9666-0","volume":"36","author":"X Gao","year":"2017","unstructured":"Gao X, Liu J, Liu X, Li L, Zheng J (2017) Cleavage and phosphorylation: important post-translational modifications of galectin-3. Cancer Metastasis Rev 36:367\u2013374. https:\/\/doi.org\/10.1007\/s10555-017-9666-0","journal-title":"Cancer Metastasis Rev"},{"key":"4401_CR12","first-page":"2374","volume":"9","author":"CM John","year":"2003","unstructured":"John CM, Leffler H, Kahl-Knutsson B, Svensson I, Jarvis GA (2003) Truncated galectin-3 inhibits tumor growth and metastasis in orthotopic nude mouse model of human breast cancer. Clin Cancer Res 9:2374\u20132383","journal-title":"Clin Cancer Res"},{"key":"4401_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-10608-9","volume":"23","author":"X Gao","year":"2023","unstructured":"Gao X, Jiang P, Wei X, Zhang W, Zheng J, Sun S, Yao H, Liu X, Zhang Q (2023) Novel fusion protein PK5-RL-Gal-3C inhibits hepatocellular carcinoma via anti-angiogenesis and cytotoxicity. BMC Cancer 23:154. https:\/\/doi.org\/10.1186\/s12885-023-10608-9","journal-title":"BMC Cancer"},{"key":"4401_CR14","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1038\/s44318-024-00106-4","volume":"43","author":"FM Haug","year":"2024","unstructured":"Haug FM, Pumroy RA, Sridhar A et al (2024) Functional and structural insights into activation of TRPV2 by weak acids. EMBO J 43:2264\u20132290. https:\/\/doi.org\/10.1038\/s44318-024-00106-4","journal-title":"EMBO J"},{"key":"4401_CR15","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3389\/fimmu.2013.00034","volume":"4","author":"G Santoni","year":"2013","unstructured":"Santoni G, Farfariello V, Liberati S, Morelli MB, Nabissi M, Santoni M, Amantini C (2013) The role of transient receptor potential vanilloid type-2 ion channels in innate and adaptive immune responses. Front Immunol 4:34. https:\/\/doi.org\/10.3389\/fimmu.2013.00034","journal-title":"Front Immunol"},{"key":"4401_CR16","doi-asserted-by":"publisher","first-page":"5471","DOI":"10.1111\/febs.12302","volume":"280","author":"A Peralvarez-Marin","year":"2013","unstructured":"Peralvarez-Marin A, Donate-Macian P, Gaudet R (2013) What do we know about the transient receptor potential vanilloid 2 (TRPV2) ion channel? FEBS J 280:5471\u20135487. https:\/\/doi.org\/10.1111\/febs.12302","journal-title":"FEBS J"},{"key":"4401_CR17","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/ni.1842","volume":"11","author":"TM Link","year":"2010","unstructured":"Link TM, Park U, Vonakis BM, Raben DM, Soloski MJ, Caterina MJ (2010) TRPV2 has a pivotal role in macrophage particle binding and phagocytosis. Nat Immunol 11:232\u2013239. https:\/\/doi.org\/10.1038\/ni.1842","journal-title":"Nat Immunol"},{"key":"4401_CR18","doi-asserted-by":"publisher","first-page":"113","DOI":"10.33549\/physiolres.932053","volume":"61","author":"D Zhang","year":"2012","unstructured":"Zhang D, Spielmann A, Wang L, Ding G, Huang F, Gu Q, Schwarz W (2012) Mast-cell degranulation induced by physical stimuli involves the activation of transient-receptor-potential channel TRPV2. Physiol Res 61:113\u2013124. https:\/\/doi.org\/10.33549\/physiolres.932053","journal-title":"Physiol Res"},{"key":"4401_CR19","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20221042","author":"C Li","year":"2024","unstructured":"Li C, Zhao M, Liu X et al (2024) Ion channel TRPV2 is critical in enhancing B cell activation and function. J Experiment Med. https:\/\/doi.org\/10.1084\/jem.20221042","journal-title":"J Experiment Med"},{"key":"4401_CR20","unstructured":"Sauer K, and Jegla, T. J. (2006) Methods for Identifying T Cell Activation Modulating Compounds. Patent Application WO\/2006\/065613."},{"key":"4401_CR21","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1158\/2326-6066.CIR-22-0531","volume":"11","author":"S Sun","year":"2023","unstructured":"Sun S, Huang C, Lu M et al (2023) Herpes Virus Entry Mediator costimulation signaling enhances CAR T-cell efficacy against solid tumors through metabolic reprogramming. Cancer Immunol Res 11:515\u2013529. https:\/\/doi.org\/10.1158\/2326-6066.CIR-22-0531","journal-title":"Cancer Immunol Res"},{"key":"4401_CR22","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41577-018-0110-7","volume":"19","author":"M Trebak","year":"2019","unstructured":"Trebak M, Kinet JP (2019) Calcium signalling in T cells. Nat Rev Immunol 19:154\u2013169. https:\/\/doi.org\/10.1038\/s41577-018-0110-7","journal-title":"Nat Rev Immunol"},{"key":"4401_CR23","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ceca.2017.01.014","volume":"63","author":"PG Hogan","year":"2017","unstructured":"Hogan PG (2017) Calcium-NFAT transcriptional signalling in T cell activation and T cell exhaustion. Cell Calcium 63:66\u201369. https:\/\/doi.org\/10.1016\/j.ceca.2017.01.014","journal-title":"Cell Calcium"},{"key":"4401_CR24","doi-asserted-by":"publisher","first-page":"6155","DOI":"10.1038\/s41467-024-50485-9","volume":"15","author":"S Zuo","year":"2024","unstructured":"Zuo S, Li C, Sun X et al (2024) C-JUN overexpressing CAR-T cells in acute myeloid leukemia: preclinical characterization and phase I trial. Nat Commun 15:6155. https:\/\/doi.org\/10.1038\/s41467-024-50485-9","journal-title":"Nat Commun"},{"key":"4401_CR25","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nri3405","volume":"13","author":"L Chen","year":"2013","unstructured":"Chen L, Flies DB (2013) Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat Rev Immunol 13:227\u2013242. https:\/\/doi.org\/10.1038\/nri3405","journal-title":"Nat Rev Immunol"},{"key":"4401_CR26","doi-asserted-by":"publisher","first-page":"e110636","DOI":"10.15252\/embj.2022110636","volume":"41","author":"Q Wang","year":"2022","unstructured":"Wang Q, Zhu T, Miao N et al (2022) Disulfiram bolsters T-cell anti-tumor immunity through direct activation of LCK-mediated TCR signaling. EMBO J 41:e110636. https:\/\/doi.org\/10.15252\/embj.2022110636","journal-title":"EMBO J"},{"key":"4401_CR27","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.it.2020.06.012","volume":"41","author":"M Vaeth","year":"2020","unstructured":"Vaeth M, Kahlfuss S, Feske S (2020) CRAC channels and calcium signaling in T cell-mediated immunity. Trends Immunol 41:878\u2013901. https:\/\/doi.org\/10.1016\/j.it.2020.06.012","journal-title":"Trends Immunol"},{"key":"4401_CR28","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1744-8069-4-51","volume":"4","author":"G Spinsanti","year":"2008","unstructured":"Spinsanti G, Zannolli R, Panti C, Ceccarelli I, Marsili L, Bachiocco V, Frati F, Aloisi AM (2008) Quantitative real-time PCR detection of TRPV1-4 gene expression in human leukocytes from healthy and hyposensitive subjects. Mol Pain 4:51. https:\/\/doi.org\/10.1186\/1744-8069-4-51","journal-title":"Mol Pain"},{"key":"4401_CR29","doi-asserted-by":"publisher","first-page":"4609","DOI":"10.1038\/s41467-024-48988-6","volume":"15","author":"L Kong","year":"2024","unstructured":"Kong L, Cheng C, Cheruiyot A et al (2024) TCAF1 promotes TRPV2-mediated Ca(2+) release in response to cytosolic DNA to protect stressed replication forks. Nat Commun 15:4609. https:\/\/doi.org\/10.1038\/s41467-024-48988-6","journal-title":"Nat Commun"},{"key":"4401_CR30","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/978-3-642-54215-2_10","volume":"222","author":"I Kojima","year":"2014","unstructured":"Kojima I, Nagasawa M (2014) Trpv2. Handb Exp Pharmacol 222:247\u2013272. https:\/\/doi.org\/10.1007\/978-3-642-54215-2_10","journal-title":"Handb Exp Pharmacol"},{"key":"4401_CR31","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1111\/febs.13306","volume":"282","author":"RK Majhi","year":"2015","unstructured":"Majhi RK, Sahoo SS, Yadav M, Pratheek BM, Chattopadhyay S, Goswami C (2015) Functional expression of TRPV channels in T cells and their implications in immune regulation. FEBS J 282:2661\u20132681. https:\/\/doi.org\/10.1111\/febs.13306","journal-title":"FEBS J"},{"key":"4401_CR32","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/brv.12820","volume":"97","author":"C Toustou","year":"2022","unstructured":"Toustou C, Walet-Balieu ML, Kiefer-Meyer MC, Houdou M, Lerouge P, Foulquier F, Bardor M (2022) Towards understanding the extensive diversity of protein N-glycan structures in eukaryotes. Biol Rev Camb Philos Soc 97:732\u2013748. https:\/\/doi.org\/10.1111\/brv.12820","journal-title":"Biol Rev Camb Philos Soc"},{"key":"4401_CR33","doi-asserted-by":"publisher","first-page":"eadk8173","DOI":"10.1126\/sciadv.adk8173","volume":"10","author":"R Duran-Romana","year":"2024","unstructured":"Duran-Romana R, Houben B, De Vleeschouwer M, Louros N, Wilson MP, Matthijs G, Schymkowitz J, Rousseau F (2024) N-glycosylation as a eukaryotic protective mechanism against protein aggregation. Sci Adv 10:eadk8173. https:\/\/doi.org\/10.1126\/sciadv.adk8173","journal-title":"Sci Adv"},{"key":"4401_CR34","doi-asserted-by":"publisher","first-page":"4264","DOI":"10.1046\/j.1432-1033.2003.03811.x","volume":"270","author":"R Jahnel","year":"2003","unstructured":"Jahnel R, Bender O, Munter LM, Dreger M, Gillen C, Hucho F (2003) Dual expression of mouse and rat VRL-1 in the dorsal root ganglion derived cell line F-11 and biochemical analysis of VRL-1 after heterologous expression. Eur J Biochem 270:4264\u20134271. https:\/\/doi.org\/10.1046\/j.1432-1033.2003.03811.x","journal-title":"Eur J Biochem"},{"key":"4401_CR35","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/jcb.10775","volume":"91","author":"JC Barnhill","year":"2004","unstructured":"Barnhill JC, Stokes AJ, Koblan-Huberson M, Shimoda LM, Muraguchi A, Adra CN, Turner H (2004) RGA protein associates with a TRPV ion channel during biosynthesis and trafficking. J Cell Biochem 91:808\u2013820. https:\/\/doi.org\/10.1002\/jcb.10775","journal-title":"J Cell Biochem"},{"key":"4401_CR36","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41589-022-01139-8","volume":"19","author":"N Su","year":"2023","unstructured":"Su N, Zhen W, Zhang H et al (2023) Structural mechanisms of TRPV2 modulation by endogenous and exogenous ligands. Nat Chem Biol 19:72\u201380. https:\/\/doi.org\/10.1038\/s41589-022-01139-8","journal-title":"Nat Chem Biol"},{"key":"4401_CR37","doi-asserted-by":"publisher","first-page":"24359","DOI":"10.1073\/pnas.1904332116","volume":"116","author":"TC Fricke","year":"2019","unstructured":"Fricke TC, Echtermeyer F, Zielke J et al (2019) Oxidation of methionine residues activates the high-threshold heat-sensitive ion channel TRPV2. Proc Natl Acad Sci U S A 116:24359\u201324365. https:\/\/doi.org\/10.1073\/pnas.1904332116","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4401_CR38","doi-asserted-by":"publisher","first-page":"78301","DOI":"10.7554\/eLife.78301","volume":"11","author":"X Mo","year":"2022","unstructured":"Mo X, Pang P, Wang Y et al (2022) Tyrosine phosphorylation tunes chemical and thermal sensitivity of TRPV2 ion channel. Elife 11:78301. https:\/\/doi.org\/10.7554\/eLife.78301","journal-title":"Elife"},{"key":"4401_CR39","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41586-019-1805-z","volume":"576","author":"RC Lynn","year":"2019","unstructured":"Lynn RC, Weber EW, Sotillo E et al (2019) c-Jun overexpression in CAR T cells induces exhaustion resistance. Nature 576:293\u2013300. https:\/\/doi.org\/10.1038\/s41586-019-1805-z","journal-title":"Nature"},{"key":"4401_CR40","doi-asserted-by":"publisher","first-page":"D1670","DOI":"10.1093\/nar\/gkae973","volume":"53","author":"S Jiang","year":"2025","unstructured":"Jiang S, Li H, Zhang L et al (2025) Generic Diagramming Platform (GDP): a comprehensive database of high-quality biomedical graphics. Nucleic Acids Res 53:D1670\u2013D1676. https:\/\/doi.org\/10.1093\/nar\/gkae973","journal-title":"Nucleic Acids Res"}],"updated-by":[{"DOI":"10.1007\/s00262-026-04499-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000}}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-026-04401-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-026-04401-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-026-04401-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T13:06:49Z","timestamp":1787144809000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-026-04401-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":40,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["4401"],"URL":"https:\/\/doi.org\/10.1007\/s00262-026-04401-3","relation":{},"ISSN":["1432-0851"],"issn-type":[{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"assertion":[{"value":"5 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00262-026-04499-5","URL":"https:\/\/doi.org\/10.1007\/s00262-026-04499-5","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal studies were conducted from March 2023 to June 2025, in accordance with the Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines 2.0, and were approved by the Experimental Animal Ethics Committee of Xuzhou Medical University (Permit number: 202303T010).","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"175"}}